Notice to Our Patients about a Data Security Incident at AMCA
We value the privacy and confidentiality of our patients’ information. Regrettably, this notice is regarding an incident that may have involved some of that information.
You may have previously heard of the incident at American Medical Collection Agency (AMCA). We used AMCA for billing collection services. On June 3, 2019, AMCA advised us that between August 1, 2018 and March 30, 2019, an unauthorized person may have had access to AMCA’s systems. Some of our patients’ information was contained in AMCA’s system, including some patients’ names, dates of medical service, names of lab or medical service providers, referring doctors, and other medical information related to services received at BioReference.
For those patients whose financial information was impacted, AMCA previously mailed letters to those patients.
This incident did not affect all BioReference patients; but only certain patients who were subject to billing collections with AMCA.
We recommend affected patients review the statements they receive from their health care providers. If they see services they did not receive, please contact the provider immediately. We deeply regret any concern or inconvenience this incident may cause our patients. We have since ceased doing business with AMCA and are taking steps to retrieve and secure all BioReference patient information contained in AMCA’s systems.
We began mailing letters to affected patients on July 29, 2019. If you believe you are affected and do not receive a letter by August 30, 2019, please call (US) 1-833-963-0524, Monday through Friday, 9:00 a.m. to 6:30 p.m. Eastern Time or (International) +44 207295090, Monday through Friday, 9:00 a.m. to 5:30 p.m. GMT.